BioMetis Technology Inc.
BioMetis Technology Inc. is a biotechnology company specializing in AI-powered protein and genome engineering through its proprietary AIDME (AI-Directed Molecular Evolution) technology. This platform enables client-driven bioproduct development across various sectors including environmental solutions (like plastic degradation), biomaterials, therapeutics, and bio-industrial applications. The company's technology integrates artificial intelligence, synthetic biology, and automation to accelerate the discovery and design of novel proteins and enzymes with desired properties. Key platforms include Polaris for novel protein discovery, Canopus for AI-directed design, Kepler for intelligent library creation, and HVS for smart sampling. BioMetis aims to provide cost-effective, high-performance, and sustainable enzyme solutions, addressing critical global challenges.
BioMetis Technology Inc.
BioMetis Technology Inc. is a biotechnology company specializing in AI-powered protein and genome engineering through its proprietary AIDME (AI-Directed Molecular Evolution) technology. This platform enables client-driven bioproduct development across various sectors including environmental solutions (like plastic degradation), biomaterials, therapeutics, and bio-industrial applications. The company's technology integrates artificial intelligence, synthetic biology, and automation to accelerate the discovery and design of novel proteins and enzymes with desired properties. Key platforms include Polaris for novel protein discovery, Canopus for AI-directed design, Kepler for intelligent library creation, and HVS for smart sampling. BioMetis aims to provide cost-effective, high-performance, and sustainable enzyme solutions, addressing critical global challenges.